StockMarketWire.com - Protein biomarker developer Proteome Sciences said it expected to swing to a full-year profit after recording stronger-than-expected sales in the fourth quarter.

Net profit for the year through December was expected at around £0.2m, compared to a loss of £1.3m on-year.

Revenue was expected to jump 57% to £4.7m.




Story provided by StockMarketWire.com